跳至主要内容
临床试验/NCT03802903
NCT03802903已完成不适用

Efficacy and Safety of Remo-Wax for Removal of Impacted Earwax; an Open, Single-arm, Non-randomised, Multicentre Clinical Study

Orion Corporation, Orion Pharma2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2019年3月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
2
主要终点
Tympanic membrane visuality

研究概览

简要总结

The study evaluates if Remo-Wax ear drops can soften impacted earwax.

详细描述

This is an open, single-arm multicentre study to confirm the efficacy and safety of a commercially available Remo-Wax ear drops containing allantoin for dissolving and removing impacted earwax. Subjects that qualify for enrollment and provide informed consent wil be treated with topical earwax softening product.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Written informed consent obtained.
  • Male or female patients over 1 year old who have cerumen impaction.
  • Presence of excessive or impacted cerumen [excessive or impacted cerumen is identified as causing partial (> 50%) or complete occlusion of at least one ear canal when attempting to visualize the tympanic membrane.

排除标准

  • Hypersensitivity to any product ingredient(s) or history of anaphylactic/anaphylactoid reactions.
  • History of tympanic membrane perforation, tympanostomy tubes, or otitis externa in the previous 6 months.
  • External ear infection.
  • Middle ear infection
  • Past ear surgery.
  • Temporal bone neoplasm.
  • Presence of known or suspected mastoiditis.
  • Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data (e.g. ear eczema or seborrhoea, ear canal stenosis, exostoses).
  • Deafness in the contralateral ear (single sided deafness).
  • Use of any ototopical drug or cerumen-removal product (with the exception of water or physiologic saline) during the preceding 3 days.
  • Use of hearing aids.
  • Participation in another drug study within 60 days prior to the start of the present study.
  • Predictable poor compliance or inability to communicate well with the investigator.

研究组 & 干预措施

Remo-Wax

Experimental

Test product will be applied into ear canal for 20-60 minutes.

干预措施: Remo-Wax (Device)

结局指标

主要结局

Tympanic membrane visuality

时间窗: 20-60 minutes

Tympanic membrane will be assessed in five grades of occlusion's severity after each treatment application. Normal - insignificant earwax present, Minimal - minimal impacted cerumen in ear canal, Mild - some impacted cerumen in ear canal, Moderate - moderate impacted cerumen in ear canal, Severe - excessive impacted cerumen in ear canal

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验